Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. Home

ESMO Expert video reports on state of art of Tumour Mutational Burden

Reporting from ELCC 2019 in Geneva, M. Pérol explains the Tumour Mutational Burden from the biomarker’s perspective, details recent assessment methods and how the test results may be useful in Non-Small Cell Lung Cancer patients to select first-line treatment.

Session: State of art of TMB testing

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.